Amlodipine is said to be a calcium channel blocker (dihydropyridine class) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle and is used as an anti-hypertensive and in the treatment of angina.
Bafna Pharma chairman and MD Mahaveer Chand as quoted by Pharmabiz saying that the approval from UK MHRA for Amlodipine 5mg and Amlodipine 10mg will provide further drive to the current expansion efforts in the European region.
"UK MHRA approval will enable Bafna Pharma to widen the customer base in Europe," Chand said.